P3 Health Partners (PIII) Stock Forecast: StockMap's 2-Week Call
PIII stock forecast: StockMap's model calls P3 Health Partners Strong Underperform for the two weeks after the Nov 19 close: it expects PIII to trail the growth index. It is a call on the gap, not a price target. Right in 5 of 6 two-week windows on PIII since Aug 21; by chance, a call on the same dates was right 59% of the time.
P3 Health Partners last closed at $1.86, -13.49% on the session.
Against the IVW growth benchmark the position is -11.16% over the forecast window.
P3 Health Partners' market cap is $13.51M as of November 19, 2026.
Calls down ↘: the model's call · the next 2 weeks, vs S&P 500 growth. The lean on a scale from −100 to +100 is -57 (behind).
Where PIII sits: sized by market cap, coloured by the day's move.
The read is built from 15 underlying insights — 3 bullish and 12 bearish.
Agreement across those insights is 80%.
49 daily calls for PIII so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.
On the fundamentals StockMap ranks P3 Health Partners in the 94th percentile on return on equity, where 100 is best.
P3 Health Partners is classified under Health Care / Health Care Providers & Services.
StockMap tracks P3 Health Partners as the 84th largest of the 87 companies it covers in the Health Care Providers & Services industry, part of the Health Care sector.
Across that group the current two-week reads are 52 Neutral, 18 Moderate Underperform, 12 Moderate Outperform and 5 Strong Underperform.
On that composite P3 Health Partners ranks 85th of 87 in the group, against a group median of -0.06.